Administration of exogenous interleukin-2 enhances obliterative airway disease in cyclosporine-treated rats following tracheal allografts

By Takao M.   Gu Y.   Shimamoto A.   Adachi K.   Namikawa S.   Yada I.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 180-181

Elsevier

Access to resources Recommend Favorite

Effect of low-molecular-weight heparin on development of cardiac allograft vascular disease following heart transplantation in rats

By Hisatomi K.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4337-4339

Elsevier

Access to resources Recommend Favorite

The role of inflammation in the development of allograft coronary disease

By Miller L.W.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2583-2584

Elsevier

Access to resources Recommend Favorite

Antiproliferative Effect of Rapamycin on Growth Factor-Stimulated Human Adult Lung Fibroblasts In Vitro May Explain Its Superior Efficacy for Prevention and Treatment of Allograft Obliterative Airway Disease In Vivo

By Nair R.V.   Huang X.   Shorthouse R.   Adams B.   Brazelton T.   Braun-Dullaeus R.   Morris R.E.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 614-615

Elsevier

Access to resources Recommend Favorite

Progression of obliterative airway disease occurs despite the removal of immune reactivity by retransplantation

By Brazelton T.R.   Adams B.A.   Cheung A.C.   Morris R.E.  

Transplantation Proceedings, Vol. 29, Iss. 6, 1997-09 ,pp. : 2613-2613

Elsevier

Access to resources Recommend Favorite